GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » BioPlus Acquisition Corp (NAS:BIOSW) » Definitions » Notes Receivable

BioPlus Acquisition (BioPlus Acquisition) Notes Receivable : $0.00 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is BioPlus Acquisition Notes Receivable?

BioPlus Acquisition's Notes Receivable for the quarter that ended in Jun. 2023 was $0.00 Mil.


BioPlus Acquisition Notes Receivable Historical Data

The historical data trend for BioPlus Acquisition's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPlus Acquisition Notes Receivable Chart

BioPlus Acquisition Annual Data
Trend Dec21 Dec22
Notes Receivable
- -

BioPlus Acquisition Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BioPlus Acquisition Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


BioPlus Acquisition Notes Receivable Related Terms

Thank you for viewing the detailed overview of BioPlus Acquisition's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


BioPlus Acquisition (BioPlus Acquisition) Business Description

Traded in Other Exchanges
N/A
Address
260 Madison Avenue, Suite 800, New York, NY, USA, 10026
Website
BioPlus Acquisition Corp is a blank check company.